clinical trial · NCT02686125
Vercise™ DBS Dystonia Prospective Study
DystoniaDeep Brain Stimulation (DBS)
brief summary
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
started
Mar 7, 2016
primary completion
Dec 1, 2030
completion
Dec 1, 2030
last updated
Aug 6, 2026
detailed description
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Subjects' improvement in disease symptoms and overall Quality of life will be assessed.
official title
Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol